B-cell depletion with obinutuzumab for the treatment of IgG4-related disease

被引：1
|
作者：
Lanzillotta, Marco [1 ,2 ]
Mapelli, Paola [1 ,3 ]
Dagna, Lorenzo [1 ,2 ]
Della-Torre, Emanuel [1 ,2 ]
机构：
[1] Univ Vita Salute San Raffaele, Milan, Italy
[2] IRCCS San Raffaele Sci Inst, Unit Immunol Rheumatol Allergy & Rare Dis UnIRAR, Via Olgettina 60, I-20132 Milan, Italy
[3] IRCCS San Raffaele Sci Inst, Nucl Med Dept, Milan, Italy
来源：
EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2023年 / 116卷
关键词：
Obinutuzumab is a safe and effective treatment; for IgG4-RD; RITUXIMAB;
D O I：
10.1016/j.ejim.2023.07.019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [1] B-cell depletion works in IgG4-related disease. What else?
    Della-Torre, Emanuel
    Dagna, Lorenzo
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 127 : 39 - 40
  • [2] B-Cell depletion therapy in IgG4-related disease: State of the art and future perspectives
    Lanzillotta, Marco
    Stone, John H.
    Della-Torre, Emanuel
    [J]. MODERN RHEUMATOLOGY, 2023, 33 (02) : 258 - 265
  • [3] B cell depletion after treatment with rituximab predicts relapse of IgG4-related disease
    Lanzillotta, Marco
    Ramirez, Giuseppe Alvise
    Milani, Raffaella
    Dagna, Lorenzo
    Della-Torre, Emanuel
    [J]. RHEUMATOLOGY, 2024,
  • [4] B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease
    Della-Torre, Emanuel
    Feeney, Eoin
    Deshpande, Vikram
    Mattoo, Hamid
    Mahajan, Vinay
    Kulikova, Maria
    Wallace, Zachary S.
    Carruthers, Mollie
    Chung, Raymond T.
    Pillai, Shiv
    Stone, John H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (12) : 2236 - 2243
  • [5] Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease
    Lanzillotta, M.
    Della-Torre, E.
    Milani, R.
    Bozzolo, E.
    Bozzalla-Cassione, B.
    Rovati, L.
    Arcidiacono, P. G.
    Partelli, S.
    Falconi, M.
    Ciceri, F.
    Dagna, L.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : S159 - S166
  • [6] Peripheral B-Cell Immunophenotyping Identifies Heterogeneity in IgG4-Related Disease
    Li, Jieqiong
    Liu, Zheng
    Zhang, Panpan
    Lin, Wei
    Lu, Hui
    Peng, Yu
    Peng, Linyi
    Zhou, Jiaxin
    Wang, Mu
    Chen, Hua
    Zhao, Lidan
    Wang, Li
    Qin, Chenman
    Hu, Chaojun
    Zeng, Xiaofeng
    Zhao, Yan
    Fei, Yunyun
    Zhang, Wen
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [7] BAFF (B-cell activating factor) expression in IgG4-related disease
    Pizzimenti, S.
    Viglino, F.
    Boita, M.
    Heffler, E.
    Novero, D.
    Bucca, C.
    Rolla, G.
    [J]. ALLERGY, 2015, 70 : 563 - 563
  • [8] Obexelimab in IgG4-related disease: B-cell inhibition as a novel therapeutic approach
    Alexander, Tobias
    Burmester, Gerd R.
    [J]. LANCET RHEUMATOLOGY, 2023, 5 (08): : E428 - E429
  • [9] Biliary Obstruction Caused by B-Cell Lymphoma Associated With IgG4-Related Disease
    Ogawa, Kazuya
    Sato, Hiroki
    Ikarashi, Satoshi
    Hayashi, Kazunao
    Terai, Shuji
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (11): : 2166 - 2166
  • [10] Optimising B-cell depletion in autoimmune disease: is obinutuzumab the answer?
    Reddy, Venkat
    Dahal, Lekh N.
    Cragg, Mark S.
    Leandro, Maria
    [J]. DRUG DISCOVERY TODAY, 2016, 21 (08) : 1330 - 1338
12345